Top Picks: new discover of 1273-86-5

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 1273-86-5, help many people in the next few years.Formula: C11H3FeO

In heterogeneous catalysis, the catalyst is in a different phase from the reactants. Formula: C11H3FeO, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 1273-86-5, name is Ferrocenemethanol. In an article£¬Which mentioned a new discovery about 1273-86-5

Strategies targeting soluble beta-amyloid oligomers and their application to early diagnosis of alzheimer?s disease

Background: Alzheimer?s Disease (AD) is the most common neurodegenerative disorder, and it is still incurable. Early diagnosis and intervention are crucial for delaying the onset and progression of the disease. Mounting evidence indicates that the neurotoxic effects might be attributed to Soluble beta-Amyloid Oligomers (SAbetaO). The SAbetaO are believed to be neurotoxic peptides more predominant than Abeta plaques in the early stage, and their key role in AD is self-evident. Unfortunately, identification of SAbetaO proves to be difficult due to their heterogeneous and transient nature. In spite of many obstacles, multiple techniques have recently been developed to target SAbetaO effectively. This review focuses on the recent progress in the approaches towards SAbetaO detection in order to shed some light on the future development of SAbetaO assays. Methods: Literatures were obtained from the following libraries: Web of Science, PubMed, EPO, SIPO, USPTO. Articles were critically reviewed based on their titles, abstracts, and contents. Results: A total of 85 papers are referenced in the review. Results are divided into three categories based on the types of detection methods: small molecule fluorescence probes, oligomer-specific antibodies and electrochemical biosensors. Finally, the improvements and challenges of these approaches applied in the early diagnosis of AD were discussed. Conclusion: This review article covers three kinds of strategies that could be translated into clinic practice and lead to earlier diagnosis and therapeutic interventions of AD.

Strategies targeting soluble beta-amyloid oligomers and their application to early diagnosis of alzheimer?s disease

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 1273-86-5, help many people in the next few years.Formula: C11H3FeO

Reference£º
Iron Catalysis in Organic Synthesis | Chemical Reviews,
Iron Catalysis in Organic Synthesis: A Critical Assessment of What It Takes To Make This Base Metal a Multitasking Champion